
Unofficial Vital Student ‘Zine
Notes from Vital Psychedelic Training class of ‘23
T-bombs away!
MAPS has recruited The Body Keeps the Score author Dr Bessel Van der Kolk.
MAPS’ latest recruit is trauma pioneer Bessel Van der Kolk author of The Body Keeps the Score
‘Gifts for the Psychedelics’ by Wardell Milan, works from David Nolan Gallery NY
Psychedelic Renaissance author Dr Ben Sessa says ‘trauma is at the root of most unnecessary human conflict and misery.’
This summer, August 2022 topical spiritual teacher Thomas Hubl launched The Collective Trauma Summit; he talks about activating a “collective immune system.”
Trauma, on the scale from ‘victim of war atrocity’ down to ‘feel nervous when you see a policeman’, is up there with depression as global burden. According to the US Department of Veteran affairs it touches 350 million people worldwide. That’s in comparison to depression’s head count of 249 million. Trauma is thought be behind many conditions for which there are no currently prescribed medications or therapies: including post-traumatic stress disorder and its domestic derivative complex ‘C’ PTSD, plus substance use and personality disorders.
“The results in terms of experiences, and the secondary analyses, are spectacular”
Dr Bessel Van der Kolk, trauma trailblazer and author of The Body Keeps the Score, is overseeing stage three trials for MAPS MDMA-Assisted Therapy for PTSD in Boston.
Back in the mid-2000s he told MAPS founder Rick Doblin, and program director Dr Michael Mithhoefer, not to try psychedelics for PTSD.
Since then, Dr Van der Kolk’s become an avid convert: “The results in terms of experiences, and the secondary analyses, are spectacular… transformations that I have not seen with any other treatment modality,” he reports.
The Federal Drug Administration has designated MAPS’ own MDMA-Assisted Therapy for PTSD program officially a ‘breakthrough therapy’, that offers ‘substantial improvement over available therapy for a life-threatening condition.’
“We have lost our minds. Here we have a chance to reclaim them”
It wants to treat a million people every year and train 300,000 therapists by 2031. In keeping with its charitable vibe, MAPS is focussed on widespread availability, including for example BIPOC and low income sectors. The model will be available free of charge, and MDMA is out of patent.
“To my mind, psychiatry lost its soul in its marriage to the drug industry as psychiatrists largely became a bunch of drug pushers,” says Dr Van der Kolk, “we have lost our minds; here, we have a chance to reclaim them. But boy, am I worried about profits. That sort of stuff can really get in the way of creating optimal healing environments. I’m really worried that people will do this by themselves or with friends or in unprotected situations, because you really open up Pandora’s box with MDMA-AT.”
Dr Van der Kolk says he “…mainly joined at that point to keep things very serious and very strict. Because I had seen how it blew up the last time,” alluding to scandals from 2015 dug up by New York Magazine’s The Cut podcast and intrepid news hounds at campaigning news source Psymposim.
“The results are spectacular… transformations that I have not seen with any other treatment”
Undergoing MDMA treatment himself convinced Van der Kolk of its potency. “I was just lying there going, ‘Oh shit, are you sure this is a party drug? Because I felt all the pain that had been dumped on me throughout the years. People asked me all the time: How do you deal with all this stuff? And I always said, ‘Oh, as long as you have a good support system and as long as you have a good marriage and you have good friends, you get to talk about your stuff, It doesn’t really become part of you.’ Well, I was wrong. On MDMA, I got to see that indeed this stuff had come inside of me, burrowed itself into the very core of my being. And it has affected me, my perception of things.”
While MDMA shrinks amygdala activity subduing fear, healing takes place by fully experiencing repressed thoughts and feelings, like during LSD and psilocybin therapy. Yet, “It’s quite different from a psychedelic,” says Dr Mithoefer, “The term proposed is ‘entactogen’ meaning it brings one closer to others and oneself,” comments on the decision to use MDMA, “but it’s not a new idea, in the 70s and 80s a number of therapists used it.” In his later Vital lecture, UK thought leader and Awakn chief Dr Ben Sessa says he believes MDMA is the best drug for therapy.
“Processing trauma in therapy can be very challenging and painful. It's not a cakewalk”
When patients take MDMA says Dr Mithoefer, “There’s often more insightfulness and less perceived loss of control. It doesn't tend to cause hallucinations, and people are more in touch with their surroundings than with psychedelics. However, even with MDMA this is all relative. If you're processing trauma in therapy, it can be very challenging and painful. So it's not a cakewalk.”
What shone out to Dr Van der Kolk was the self-compassion, evolving rapidly into acceptance, that MDMA treatment accessed inside its patients. “They stopped judging and beating up on themselves. They had a sense of internal generosity, a capacity for self-acceptance: and with that, the accepting of other people. They’d no longer defend against parts of themselves they couldn’t stand… and project on others.” What would normally be ‘triggering’ leading to self-defeating reactions is purged from the system… once felt in full.
“Part of functioning well is knowing what you feels, know, and needs to be done”
Pioneering child psychologist John Bowlby famously said, ‘What cannot be told to the mother cannot be told to the self.’ Resulting from this inner conflict is ‘alexithymia – ‘experiential avoidance of emotions as an emotion regulation strategy.’ Canonical 20th century psychoanalyst Joyce McDougall called it ‘disaffection’, “an inability to contain and reflect upon an excess of affective experience.”
The disaffected respond by ‘pulverising all trace of feeling, so that an experience which has caused emotional flooding is not recognised as such and therefore cannot be contemplated,’ according to 1989’s Theatre of the Body. This sounds like most people I know, to be honest. (McDougall also identified ‘normopathy’, the fear of difference).
Alexithymia was coined in 1973 by psychiatrist John C. Nemiah, a Yale and Harvard Medical school graduate and editor of the American Journal of Psychiatry. Some folks think it’s just a personality trait; ‘guys who can’t express their emotions’. Poor emotional intelligence is certainly a hallmark. Sufferers can certainly feel ‘happy’ and ‘sad’ but have little vocabulary to examine or discuss their state any further. In their relationships they are distant, over-rationalised and lack intimacy. They often lack assertiveness, and make decisions without taking their emotions into account leading to a dissatisfaction they cannot pin down. This develops into dysphoria, ‘a profound sense of unease.’
One of the most difficult parts of my own ADHD diagnosis was the chapter in Gabor Maté’s Shattered Minds that told me I didn’t have an identity.
“What you see in the MDMA-assisted therapy is that people have a self. They say, ‘This is who I am’.”
Instead I was a series of behavioural diktats intended to please others, or get them off my back at least.
“The latest neuroscience stuff in the area of trauma is very much about the loss of sense of self that comes from it. And indeed the vast majority of our subjects in the MDMA-assisted therapy study had terrible Alexithymia scores,” said Dr Van der Kolk on Norway’s Psykologvirke podcast, “as long as you live with caregivers who don’t see you, that really impairs your capacity to know who you are and what you’re feeling. This is very much part of becoming a well functioning human being: to know what this creature that you inhabit feels, and knows, and needs to be done.”
Beautifully, “What you see in the MDMA-assisted therapy is that people have a self,” observes Dr Van der Kolk, “They say, ‘this is who I am. This is what I feel, this is what’s important to me. That’s what’s unimportant to me. And I’m no longer dependent on what you feel to dictate what I feel. I have my own feelings’.”
More MDMA therapy articles here on New Psychonaut:
Homestasis is where the heart is
Seeing your shrink wil never be the same again after MDMA-AT.
Seeing your shrink will never be the same after MDMA-AT
By Jeppe Hein on display at Albion Fields till 22 Sept 2020
MDMA-AT consists of three ‘blindfold’ experiences each a month apart.
These are punctuated by fifteen therapy sessions dedicated to assessment, preparation and integration. Each stage – indeed, each appointment – includes a detailed, mindful strategy.
The ‘inner healer’ concept is described as a the mind mending itself in the same way the body might gradually heal a graze or cut. The method and therapy is described as the dressing that might be put on a wound, providing the correct environment for the miracle of human evolution to do its stuff.
Homeostatic instinct is the term used by men and women of science for the inner healer. Freud (who isn’t dead, it’s just a headline. Well he is physically of course) said instinct is a ‘demand made on the mind by the body’. Back in the renaissance Spinoza wrote that ‘Joy is associated with a transition of the organism to greater perfection’ as noted by top scholar Antonio Damasio.
Could denial of our human instincts – personal drive, logos, awen, true will, whatever you want to call it – land us in a chronic long-term disease ward? Not serving animal instincts certainly does.
“It’s only when the process begins that they understand”
During the MDMA time itself, patients are encouraged to spend time both talking to the therapists and by themselves processing beneath the blindfold, “although we are focussing on the inner experience” says Michael, and discussions during the experiences are intended to facilitate “a self directed experience. They don’t even have to wear the blindfold if they don’t want to, but often they end up doing so.”
Patients are shepherded towards their own “personal alchemy” to quote Michael, a bespoke therapy style unique to them. This can be cultivated by honing one’s ‘self energy’, a calm, curious and compassionate state that provides an emotional container for patients to open up to themselves.
“Usually therapists have goals or ideas of where they should go, but the patient directs that,” notes Annie, “which can be difficult for some people – they want to be told how they can cure their PTSD! It’s only when the process begins that they understand.”
The MAPS dyad and MDMA-AT designers quote psychology colossus, emeritus professor at Stanford and When Nietzsche Wept author Irvin David Yalom, who wrote, “The therapist must strive to create a new therapy for each patient, or strive to encourage the patient to create a new one for themselves.”
Surprisingly perhaps, patients’ individual inner work often has a similarity to popular methods. One that come up in particular is Internal Family Systems (IFS), where patients discuss talking to the ‘parts’ of themselves that play different roles in their ruminations.
“The therapist must strive to create a new therapy for each patient”
“We see again the value of allowing space and time for something unexpected, terrifying or beautiful, to come through from the inner healing intelligence”
A patient who allowed themselves to be filmed for educational purposes discussed acknowledging, listening to, and comforting his aggressive/defensive self – Jungian shadow work, essentially. I asked Dr Michael Mithoefer in the after-lecture Q&A if he had suggested the method: “if I even had, I wouldn’t have described it as ‘shadow work, which is part of the work of Sigmund Freud’s protege Carl Jung’. I would’ve put it in layman’s terms.”
‘Imaginal exposure’ – fictional examinations of how thoughts and feelings may play out in reality – and ‘active imagination’ – using fantastical metaphors to better comprehend stark reality in classic ‘psychedelic insight’ style – are two methods patients turn to naturally. Call it a ‘Jungian archetype’ or a ‘spirit animal’, it’s imaginative right brain activity processing complex thoughts to achieve balance. “We see again the value of allowing space and time for something unexpected, terrifying or beautiful, to come through from the inner healing intelligence,” says Michael.
“We’re clear that the process isn’t designed to suppress their symptoms… but get to the root”
Transference issues can be used to highlight areas of behaviour to work on. Freudian psychodynamics, the examination of unconscious motivations, is still relevant despite me declaring ‘Freud is dead’ last week.
Other methods patients organically, roughly, incline towards range from the practical such as somatic experiencing (feeling trauma in the body) and corrective attachment (establishing a healthy behaviour model) to the totally way-out transpersonal.
“We’re keen to normalise transpersonal experiences, letting the patent know we won’t think they’re weird. Transpersonal experiences aren’t essential. Patients that don’t have them tend to do very well also.”
What is impressed upon patients is that they will get the most benefit from leaning in to their inner turmoil, not suppressing uncomfortable feelings but letting them flow forth instead. Moreover, this is not entirely linear, themes can wax and wane in importance, and it might be unpleasant and uncomfortable in places: “They might get worse before they get better. We are clear that the process is not designed to suppress their symptoms, but get to the root.”
The celebrated MAPS dyad call processing under the blindfold ‘going inside’.
“They never have to, and we are aware when they are avoiding it and help with that. But we will say ‘maybe now is a good time to go inside’ when we think it’s a good point in conversation for them to process. If they come up with a connection themselves it’s more powerful – for example, ‘I notice every time I start talking about ‘x’ I ask to go to the bathroom.’
We explore that first before prompting them to go inside: ‘Would you like to experiment with that for a little bit?’ We make it clear they don’t have to hang out with something they want to avoid. It’a matter of is it needed at all, timing, and offering the option so it doesn’t sound like we’re pressuring them.”
The hardest part, say the pair, who’ve worked with MAPS for two decades, is not barging into the process. “IFS creator Dick Schwartz [who’ll be talking to Vital students later this year] uses the acronym ‘WAIT’,” says Michael, “why – am – I – talking?”
The therapist is not the ‘healer’ – that’s inside the patient. Defence mechanisms mean it can be a long struggle to help patients come to the conclusions that would benefit them: for instance, decorated commandos who refusing to believe that their PTSD could have anything to do with all the combat missions, or rape victims desperate to bury their experience. “One patient commented, ‘I now have a battle plan when before I was thrashing about in the undergrowth’,” says Michael.
Drugs are the Love
MDMA for couples therapy: 4/4 octopuses can’t be wrong.
MDMA for couples' therapy: 4/4 octopuses can’t be wrong
Ithell Colquhoun, ‘Song of Songs’ via Unit London
Can the inner healer mend a broken relationship?
Next up for MAPS therapy program designers Dr Michael Meithofer and his wife Annie AKA ‘Annie and Michael’ in spacespeak, is MDMA for couples’ counselling.
“We knew that MDMA was useful for communication… and some of the other anecdotal things about it,” Annie told none other than Professor David Nutt on the Drug Science podcast (where you can hear Dr Nutt, the David Attenborough of drugs, a UK national treasure say ‘Back to the show!’)
Annie collaborated on the initial research for a new era in MDMA couples’ therapy with Toronto’s Dr Anne Wagner. The Remedy clinic director has come up during further investigations into juicy subjects two weeks in a row (sync). Last week it was in a call for further research into psychedelic treatment for borderline personality disorder (BPD).
Yet Dr Wagner is not the only intrepid sailor of the soul cooking up excellent experiments using ecstasy. John Hopkins’ university neuroscience department, not to be outdone, gave E to octopuses. They’d noticed ‘that octopuses and humans had nearly identical genomic codes for the transporter that binds the neurotransmitter serotonin to the neuron's membrane.’
The California double-spot octopus is a solitary creature, barely interacting with others of its kind besides once a year, briefly, for mating. Even then the male uses a sex arm and it looks like mid-air refuelling.
Would you believe though, that when researchers put the octopuses ‘in a beaker containing a liquified version of the drug’ according to National Geographic, they exhibited significantly more social behaviour?
‘Particularly telling, said scientist Gul Dolen, was that after being returned to their tanks at Woods Hole Oceanographic Institute in Massachusetts, the octopuses went on to reproduce.’
During the Q&A after Annie and Michael’s lecture the pair were asked about giving MDMA to animals. After all, dogs are given anti-depressants. When I got my own chance to talk to them, I celebrated group ceremonial use of the ecstasy sacrament in the form of our rave culture then made a bad taste joke about giving MDMA to our pets hadn’t gone nearly as well. Now we know to shove them in a beaker of it.
’At no point did the octopuses ink, which would be a sign of stress,’ Dr Dolan told Nat Geo in response to all of our ethical concerns.
Inner space of safety
MDMA boasts striking therapeutic properties beyond increased connection.
MDMA boasts striking therapeutic properties beyond increased connection
Chemical X, ‘Spectrum’
“I believe MDMA is the ideal drug for psychotherapy,” says non-nonsense Awakn founder and trauma expert Dr Ben Sessa.
The exciting bits are MDMA triggers a ‘oxytocin-dependent reopening’ of a ‘social reward learning critical period’. It puts your brain in the state of early childhood and adolescence, when it establishes key neural pathways. The hypothesis is that dysfunctional thought patterns can be adjusted in this state.
MDMA increases pre-frontal cortex activity like an ADHD stimulant, lowers activity in the amygdala ‘fear centre’ deep in the reptile brain, and is notable for its relationship to both dopamine and serotonin. It creates an ‘optimal level of arousal’ that is neither too little nor too much for the brain to process its thoughts and instincts.
Added neuroplasticity helps memories reconsolidate so patients feel safer in safe settings, for example. MDMA scored strongly on PTSD patients with dissociative symptoms who often prove the toughest to treat. Trial data was consistent across the five test sites spread globally.
Ecstasy was first named ‘Adam’ then ‘Empathy’
Trial subjects previously suffered severe symptoms that had resisted regular therapeutic treatment for many years.
‘MDMA was invented for shellshocked soldiers’ is a trope I may be guilty of falling for. It wasn’t an appetite suppressant either when patented by Merck in 1914. Forensic research into the German pharmaceutical firm suggests a humbler origins for the love drug as merely a stepping-stone towards developing an alternative to hydrastinine, used to prevent internal bleeding particularly in the uterus.
The military nonetheless had it knocking around for whatever reason in the 1950s around the first time scientists tested MDMA on humans and recorded the results. These soon reached the keen ears of Alexander Shulgin, who says he first synthesised it in 1965. It was originally named ‘Adam’, and also ‘Empathy’.
Patients during MDMA-AT are given 125mg of what the subculture renamed ‘ecstasy’ with up to 75mg of booster. Apocryphally, a friend who took part in an Imperial MDMA trial said it was hella strong.
Each ‘Zine features the most mind-blowing bits I scrawled down during each of Vital’s exclusive live lectures by the finest minds in the space. Browse them by issue or go straight to the introductions with lecturer details.
And search by the topics: Traditional and Modern Approaches, Therapy, Space Holding, Medical and Clinical, and Integration. Funnies at the end too.
Psychedelics are the psychic antibiotic.